Cargando…
Regulation of PD-L1 expression in non–small cell lung cancer by interleukin-1β
INTRODUCTION: Programmed cell death–ligand 1 (PD-L1) is a biomarker for prediction of the clinical efficacy of immune checkpoint inhibitors in various cancer types. The role of cytokines in regulation of PD-L1 expression in tumor cells has not been fully characterized, however. Here we show that int...
Autores principales: | Hirayama, Aiko, Tanaka, Kentaro, Tsutsumi, Hirono, Nakanishi, Takayuki, Yamashita, Sho, Mizusaki, Shun, Ishii, Yumiko, Ota, Keiichi, Yoneshima, Yasuto, Iwama, Eiji, Okamoto, Isamu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10333574/ https://www.ncbi.nlm.nih.gov/pubmed/37441079 http://dx.doi.org/10.3389/fimmu.2023.1192861 |
Ejemplares similares
-
MicroRNA‐326 negatively regulates CD155 expression in lung adenocarcinoma
por: Nakanishi, Takayuki, et al.
Publicado: (2023) -
Increased plasma levels of damage-associated molecular patterns during systemic anticancer therapy in patients with advanced lung cancer
por: Inoue, Hiroyuki, et al.
Publicado: (2021) -
Immunostimulatory oncolytic activity of coxsackievirus A11 in human malignant pleural mesothelioma
por: Okamura, Koji, et al.
Publicado: (2022) -
Pleuroparenchymal fibroelastosis secondary to autologous peripheral blood stem cell transplantation: A case report
por: Egashira, Ayaka, et al.
Publicado: (2023) -
Association of thyroid transcription factor-1 (TTF-1) expression with efficacy of PD-1/PD-L1 inhibitors plus pemetrexed and platinum chemotherapy in advanced non-squamous non-small cell lung cancer
por: Ibusuki, Ritsu, et al.
Publicado: (2022)